GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Neuca SA (WAR:NEU) » Definitions » EV-to-EBIT

Neuca (WAR:NEU) EV-to-EBIT : 14.17 (As of Dec. 12, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Neuca EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Neuca's Enterprise Value is zł4,197 Mil. Neuca's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was zł296 Mil. Therefore, Neuca's EV-to-EBIT for today is 14.17.

The historical rank and industry rank for Neuca's EV-to-EBIT or its related term are showing as below:

WAR:NEU' s EV-to-EBIT Range Over the Past 10 Years
Min: 9.58   Med: 14.18   Max: 21.56
Current: 14.16

During the past 13 years, the highest EV-to-EBIT of Neuca was 21.56. The lowest was 9.58. And the median was 14.18.

WAR:NEU's EV-to-EBIT is ranked worse than
55.06% of 89 companies
in the Medical Distribution industry
Industry Median: 12.78 vs WAR:NEU: 14.16

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Neuca's Enterprise Value for the quarter that ended in Sep. 2024 was zł4,211 Mil. Neuca's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was zł296 Mil. Neuca's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 7.04%.


Neuca EV-to-EBIT Historical Data

The historical data trend for Neuca's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuca EV-to-EBIT Chart

Neuca Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.78 14.29 17.76 12.03 15.41

Neuca Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.23 15.41 14.36 15.16 14.21

Competitive Comparison of Neuca's EV-to-EBIT

For the Medical Distribution subindustry, Neuca's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neuca's EV-to-EBIT Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Neuca's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Neuca's EV-to-EBIT falls into.



Neuca EV-to-EBIT Calculation

Neuca's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=4197.104/296.254
=14.17

Neuca's current Enterprise Value is zł4,197 Mil.
Neuca's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł296 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neuca  (WAR:NEU) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Neuca's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2024 ) =EBIT / Enterprise Value (Q: Sep. 2024 )
=296.254/4210.85424
=7.04 %

Neuca's Enterprise Value for the quarter that ended in Sep. 2024 was zł4,211 Mil.
Neuca's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł296 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neuca EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Neuca's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Neuca Business Description

Traded in Other Exchanges
N/A
Address
ul. Forteczna 35?37, Torun, POL, 87-100
Neuca SA is a wholesale distributor of pharmaceuticals in Poland. The company's segment includes Pharmacy wholesale; Manufacture of pharmaceuticals; Outpatient medical care clinics; Clinical trials and Insurance activities. It generates maximum revenue from the Pharmacy wholesale segment.